Physician profile
James Ryden
NPI 1154907640
$262.98
in general payments reported to CMS, 2019-2025
8 companies · $212 in 2025
The $212 reported for 2025 was more than what 75% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $50.87 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $262.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $101.15 | 2024-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $42.82 | 2024-2025 | Vaxelis, Gardasil 9, Rotateq |
| Tris Pharma INC | $26.22 | 2025 | Onyda Xr |
| Ars Pharmaceuticals Operations, INC. | $21.79 | 2025 | Neffy |
| Phadia US INC. | $20.39 | 2025 | Immunocap |
| Collegium Pharmaceutical, INC. | $18.26 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $16.60 | 2024 | |
| Cranial Technologies, INC | $15.75 | 2025 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ryden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.